Jove
Visualize
Contact Us

Related Concept Videos

Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

278
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
278
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

241
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
241
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

265
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
265
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

227
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
227
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

259
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
259
Hybridoma Technology01:31

Hybridoma Technology

17.8K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
17.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cost effectiveness of comprehensive geriatric assessment: a systematic review.

Health economics review·2026
Same author

The sound of longevity: music and technology for healthy ageing.

Aging clinical and experimental research·2026
Same author

Usefulness of the BRIEF-Multidimensional Prognostic Index (BRIEF-MPI) to identify older adults' healthcare needs to be addressed with a Personalized Prevention Program in general practice: preliminary data from the PrimaCare_P3 study.

BMC primary care·2025
Same author

Age-related changes of the gastrointestinal tract.

The lancet. Gastroenterology & hepatology·2025
Same author

Cognitive stimulation in Parkinson's disease with mild cognitive impairment.

Journal of neurology·2025
Same author

Usefulness of a new digital version of the MPI-SVaMA (MPI-SVaMA Digit) in predicting short- and long-term mortality in community-dwelling older people.

Aging clinical and experimental research·2025
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Feb 13, 2026

Kinematics and Ground Reaction Force Determination: A Demonstration Quantifying Locomotor Abilities of Young Adult, Middle-aged, and Geriatric Rats
10:28

Kinematics and Ground Reaction Force Determination: A Demonstration Quantifying Locomotor Abilities of Young Adult, Middle-aged, and Geriatric Rats

Published on: February 22, 2011

20.2K

Technology in geriatrics.

Alberto Pilotto1, Raffaella Boi1, Jean Petermans2

  • 1Department of Geriatric Care, Orthogeriatrics and Rehabilitation, Frailty Area, E.O. Galliera Hospital, National Relevance & High Specialization Hospital, Genoa, Italy.

Age and Ageing
|March 17, 2018
PubMed
Summary
This summary is machine-generated.

Technology can enhance independence and quality of life for older adults, but psychosocial, ethical, and cost barriers exist. Interdisciplinary collaboration is key to integrating assistive technologies into healthcare systems.

More Related Videos

Isolation of Soil Microorganisms Using iChip Technology
05:33

Isolation of Soil Microorganisms Using iChip Technology

Published on: January 10, 2025

4.0K
An Open Source Technology Platform to Manufacture Hydrogel-Based 3D Culture Models in an Automated and Standardized Fashion
08:29

An Open Source Technology Platform to Manufacture Hydrogel-Based 3D Culture Models in an Automated and Standardized Fashion

Published on: March 31, 2022

4.9K

Related Experiment Videos

Last Updated: Feb 13, 2026

Kinematics and Ground Reaction Force Determination: A Demonstration Quantifying Locomotor Abilities of Young Adult, Middle-aged, and Geriatric Rats
10:28

Kinematics and Ground Reaction Force Determination: A Demonstration Quantifying Locomotor Abilities of Young Adult, Middle-aged, and Geriatric Rats

Published on: February 22, 2011

20.2K
Isolation of Soil Microorganisms Using iChip Technology
05:33

Isolation of Soil Microorganisms Using iChip Technology

Published on: January 10, 2025

4.0K
An Open Source Technology Platform to Manufacture Hydrogel-Based 3D Culture Models in an Automated and Standardized Fashion
08:29

An Open Source Technology Platform to Manufacture Hydrogel-Based 3D Culture Models in an Automated and Standardized Fashion

Published on: March 31, 2022

4.9K

Area of Science:

  • Gerontology
  • Assistive Technology
  • Health Informatics

Background:

  • Growing interest in technology for aging populations from industry, government, and healthcare.
  • Key challenge: determining technology's role in enhancing independence, quality of life, and reducing care costs for older adults.

Purpose of the Study:

  • To explore the potential of various technologies in supporting older adults.
  • To identify promising applications and barriers to technology adoption in aging.

Main Methods:

  • Review of information and communication technologies, assistive technologies, and human-computer interaction for older adults.
  • Analysis of clinical applications in housing, safety, mobility, rehabilitation, and communication.

Main Results:

  • Promising applications include housing/safety, mobility/rehabilitation, and communication/quality of life improvements.
  • Barriers include psychosocial and ethical issues, costs, and fear of reduced human interaction.
  • Lack of robust clinical trials suggests traditional biomedical models may be insufficient for evaluating these technologies.

Conclusions:

  • Successful technology integration requires interdisciplinary collaboration.
  • Technologies must be seamlessly integrated into existing health and social service systems.
  • Focus on fitting technology into the everyday lives of older adults is crucial.